Summary
Molbio Diagnostics has set the price range for its initial public offering, aiming to raise ₹940 crore, with subscriptions opening on August 10. The IPO will include both fresh share issuance and an offer for sale, managed by Kotak Mahindra Capital and IIFL Capital Services, with Jefferies India and Motilal Oswal as book-running lead managers.